Published in Protein Sci on May 27, 2008
α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem (2012) 2.31
Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease. J Biol Chem (2009) 0.83
Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem (2009) 0.83
Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. CNS Neurosci Ther (2009) 0.83
Physio-pathological roles of transglutaminase-catalyzed reactions. World J Biol Chem (2010) 0.81
Transglutaminase activation in neurodegenerative diseases. Future Neurol (2009) 0.79
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. J Pathol (2011) 0.79
Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Sci (2010) 0.79
The Role of α-Synuclein and LRRK2 in Tau Phosphorylation. Parkinsons Dis (2015) 0.78
γ-Glutamylamines and neurodegenerative diseases. Amino Acids (2012) 0.76
Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's Disease. Metabolites (2017) 0.75
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol (2001) 4.27
Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry (2001) 2.96
Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol (2002) 2.92
Lewy bodies. Proc Natl Acad Sci U S A (2006) 2.15
Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J Biol Chem (1999) 1.44
Helix periodicity, topology, and dynamics of membrane-associated alpha-synuclein. Protein Sci (2005) 1.41
Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A (2003) 1.40
Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res (2006) 1.28
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res (2001) 1.15
Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants. Biophys J (2006) 1.12
Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease. FASEB J (2004) 1.05
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol (2008) 0.99
Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide. Biochem J (1995) 0.99
Transglutaminase is linked to neurodegenerative diseases. J Neuropathol Exp Neurol (2007) 0.95
Transglutaminase cross-linking of the tau protein. J Neurochem (1995) 0.93
Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking. Biochemistry (2005) 0.91
Induction of tissue transglutaminase in human peripheral blood monocytes. J Exp Med (1984) 0.88
Paradoxical inhibition of protein aggregation and precipitation by transglutaminase-catalyzed intermolecular cross-linking. J Biol Chem (2005) 0.83
SNARE assembly and disassembly exhibit a pronounced hysteresis. Nat Struct Biol (2002) 2.40
Dependence of alpha-synuclein aggregate morphology on solution conditions. J Mol Biol (2002) 2.26
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J (2010) 2.26
Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med (2008) 1.83
Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry (2004) 1.77
Antiparallel arrangement of the helices of vesicle-bound alpha-synuclein. J Am Chem Soc (2008) 1.45
NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J (2004) 1.41
Micromechanical bending of single collagen fibrils using atomic force microscopy. J Biomed Mater Res A (2007) 1.38
Dynamic fluorescence anisotropy imaging microscopy in the frequency domain (rFLIM). Biophys J (2002) 1.34
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol (2006) 1.30
Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy. J Mol Biol (2004) 1.24
Cellular polyamines promote the aggregation of alpha-synuclein. J Biol Chem (2002) 1.21
Fast, ultrasensitive virus detection using a Young interferometer sensor. Nano Lett (2007) 1.21
Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochim Biophys Acta (2009) 1.20
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol (2005) 1.20
Nanomechanical properties of α-synuclein amyloid fibrils: a comparative study by nanoindentation, harmonic force microscopy, and Peakforce QNM. Nanoscale Res Lett (2011) 1.16
Refractive index sensing of green fluorescent proteins in living cells using fluorescence lifetime imaging microscopy. Biophys J (2008) 1.14
(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) (2007) 1.14
Covalent microcontact printing of proteins for cell patterning. Chemistry (2006) 1.12
Resonance energy transfer in a calcium concentration-dependent cameleon protein. Biophys J (2002) 1.12
Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants. Biophys J (2006) 1.12
Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound alpha-synuclein. Chemphyschem (2010) 1.08
Spin-label EPR on alpha-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices. Chembiochem (2008) 1.08
Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol (2009) 1.07
Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism. PLoS One (2010) 1.05
Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev (2007) 1.04
A stable lipid-induced aggregate of alpha-synuclein. J Am Chem Soc (2010) 1.01
Direct observation of nanomechanical properties of chromatin in living cells. Nano Lett (2007) 0.99
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol (2008) 0.99
Oligomerization of DsRed is required for the generation of a functional red fluorescent chromophore. FEBS Lett (2002) 0.99
Concentration dependence of alpha-synuclein fibril length assessed by quantitative atomic force microscopy and statistical-mechanical theory. Biophys J (2008) 0.98
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol (2012) 0.97
Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing. FEBS Lett (2008) 0.97
Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Brain Pathol (2008) 0.96
Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior. J Neurosci (2011) 0.94
Single-molecule FRET reveals structural heterogeneity of SDS-bound alpha-synuclein. Chembiochem (2009) 0.94
Nanometer arrays of functional light harvesting antenna complexes by nanoimprint lithography and host-guest interactions. J Am Chem Soc (2008) 0.94
Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients. Acta Neuropathol Commun (2014) 0.92
Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch Toxicol (2014) 0.92
Force spectroscopy and fluorescence microscopy of dsDNA-YOYO-1 complexes: implications for the structure of dsDNA in the overstretching region. Nucleic Acids Res (2010) 0.91
Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions. Neurobiol Dis (2009) 0.91
Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain. Brain Pathol (2010) 0.90
Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide pool. J Biol Chem (2012) 0.90
NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic Biol Med (2006) 0.90
Creating nanopatterns of His-tagged proteins on surfaces by nanoimprint lithography using specific NiNTA-histidine interactions. Small (2007) 0.90
Hunting the chameleon: structural conformations of the intrinsically disordered protein alpha-synuclein. Chembiochem (2012) 0.89
Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp Gerontol (2007) 0.89
The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res (2002) 0.89
Integrin-dependent activation of the JNK signaling pathway by mechanical stress. PLoS One (2011) 0.88
Molecular composition of sub-stoichiometrically labeled α-synuclein oligomers determined by single-molecule photobleaching. Angew Chem Int Ed Engl (2012) 0.87
Long-range energy propagation in nanometer arrays of light harvesting antenna complexes. Nano Lett (2010) 0.87
Directed formation of micro- and nanoscale patterns of functional light-harvesting LH2 complexes. J Am Chem Soc (2007) 0.87
Atomic force microscopy under controlled conditions reveals structure of C-terminal region of α-synuclein in amyloid fibrils. ACS Nano (2012) 0.86
Room temperature excitation spectroscopy of single quantum dots. Beilstein J Nanotechnol (2011) 0.86
Spatially resolved frequency-dependent elasticity measured with pulsed force microscopy and nanoindentation. Nanoscale (2012) 0.86
Room temperature spectrally resolved single-molecule spectroscopy reveals new spectral forms and photophysical versatility of aequorea green fluorescent protein variants. Biophys J (2004) 0.86
Inhibition of α-synuclein aggregation by small heat shock proteins. Proteins (2011) 0.86
α-Synuclein oligomers: an amyloid pore? Insights into mechanisms of α-synuclein oligomer-lipid interactions. Mol Neurobiol (2012) 0.86
Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability. Eur J Biochem (2003) 0.86
Alpha-synuclein binds to the inner membrane of mitochondria in an α-helical conformation. Chembiochem (2014) 0.85
Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. Neuroimage (2005) 0.85
Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration? PLoS One (2011) 0.85
Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease. Neurobiol Dis (2011) 0.85
Nanophotonic control of the Förster resonance energy transfer efficiency. Phys Rev Lett (2012) 0.85
Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging. Parkinsonism Relat Disord (2006) 0.85
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach. Neurobiol Dis (2010) 0.85
Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol Aging (2009) 0.85
Microbioreactors for Raman microscopy of stromal cell differentiation. Anal Chem (2010) 0.85
New insights into the photophysics of DsRed by multiparameter spectroscopy on single proteins. J Phys Chem B (2008) 0.85
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease. Neurochem Int (2011) 0.85
Double-stranded DNA stimulates the fibrillation of alpha-synuclein in vitro and is associated with the mature fibrils: an electron microscopy study. J Mol Biol (2004) 0.84
Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol (2002) 0.84
Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions. Free Radic Biol Med (2010) 0.84
Biofunctionalized lipid-polymer hybrid nanocontainers with controlled permeability. Nano Lett (2008) 0.84
Single-molecule spectroscopy of fluorescent proteins. Anal Bioanal Chem (2008) 0.83
Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton. J Biol Chem (2014) 0.83
Strategies for patterning biomolecules with dip-pen nanolithography. Small (2011) 0.83
Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders. Free Radic Biol Med (2012) 0.83
Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease. Curr Protein Pept Sci (2010) 0.83
Membrane interactions and fibrillization of α-synuclein play an essential role in membrane disruption. FEBS Lett (2014) 0.82
Anchoring of histidine-tagged proteins to molecular printboards: self-assembly, thermodynamic modeling, and patterning. Chemistry (2008) 0.82
Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients. Brain Pathol (2013) 0.82
A comparative analysis of the aggregation behavior of amyloid-β peptide variants. FEBS Lett (2012) 0.82
Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration? Brain Pathol (2010) 0.81
Intracellular manipulation of chromatin using magnetic nanoparticles. Chromosome Res (2008) 0.81
A molecular beacon strategy for real-time monitoring of triplex DNA formation kinetics. Antisense Nucleic Acid Drug Dev (2002) 0.81
α-Synuclein oligomers distinctively permeabilize complex model membranes. FEBS J (2014) 0.81
Directed assembly of functional light harvesting antenna complexes onto chemically patterned surfaces. Nanotechnology (2007) 0.80
Manipulation of the local density of photonic states to elucidate fluorescent protein emission rates. Phys Chem Chem Phys (2009) 0.80